Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

University of Bonn. (4/25/22). "Press Release: Successful Spin-off from the University of Bonn and LS. APIS Assay Technologies Ltd Acquires Startup Clickmer Systems".

Organisations Organisation University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn)
  Organisation 2 Clickmer Systems GmbH (formerly spin-off project from Univ of Bonn)
  Group APIS Assay Technologies (Group)
Products Product Clickmers (ligand binding technology)
  Product 2 molecular diagnostics
Index term Index term Clickmer Systems–APIS Assay Technologies: investment, 202204 acquisition of Clickmer Systems for single-digit €m by APIS Assay Technologies Ltd
Persons Person Schorr, Joachim (APIS Assay Technologies 202304 CEO before Caris Life Sciences + Qiagen + Hoechst)
  Person 2 Karnowski, Nora (Clickmer Systems 202204)

APIS Assay Technologies Ltd acquires startup Clickmer Systems, which is developing antibody alternative

The British company APIS Assay Technologies Ltd has acquired the University of Bonn's spin-off project Clickmer Systems, which was further developed at the Life Science Inkubator (LSI), for a single-digit million euro sum. The startup is developing clickmers as a synthetic alternative to antibodies that can be utilized in research and medical diagnostics. Clickmers can be used, for example, to detect viral infections, determine vaccination status or detect rejection reactions after organ transplants. The company now wants to bring the innovative products to market quickly so that users can benefit from them in the near future.

The Clickmer Systems team at the Gründer- und Technologiezentrum Rheinbach (from left): - Stefanie Büsch, Dr. Joachim Schorr, Dr. Maren Hamann, Prof. Dr. Günter Mayer, Dr. Nora Karnowski, Prof. Dr. Michael Famulok and Dr. Elisa Merklinger.

Antibodies, which are made of proteins and keep pathogens at bay, are an important part of the immune system. Medical applications include vaccines, cancer therapy and diagnostics. The research group of Prof. Dr. Günter Mayer of the LIMES Institute at the University of Bonn has succeeded in replacing such antibodies with synthetic "clickmers" for specific applications. The technology is based on pioneering work by Prof. Dr. Michael Famulok, who also conducts research at the LIMES Institute.

"In recent years, our team has been able to demonstrate the applicability of the clickmer technology and its economic usability," says Prof. Mayer, who is also the representative of transfer at the University of Bonn. "Now it's a matter of working with APIS Assay Technologies to quickly bring our developments to commercial market readiness within in-vitro diagnostics so that users can benefit."

With the company from Manchester (England), an experienced developer of tests for molecular diagnostics is now taking over the development toward market launch. "Apis Assay Technologies harness the power of systems biology, big data, and novel synthetic clickmer technology to create diagnostic tests. These innovative tests can deliver significant improvements in disease prediction and prevention," says Dr. Ian Kavanagh, Chief Operating Officer (COO) APIS Assay Technologies.

The startup was developed over the past three years at the Life Science Inkubator until it was ready for investment. The project was funded by the German Federal Ministry of Education and Research (BMBF) with 1.7 million euros. "The technology and the team convinced LSI in the evaluation process, so that we have jointly developed the project to commercialization readiness over the past three years," says LSI Managing Director Dr. Jörg Fregien.

Support from the team of the transfer center enaCom

The startup also received support from the technology transfer department of the University of Bonn and the new enaCom center. The team provided advice in areas including marketing and patenting. "We are thrilled by the rapid development of Clickmer Systems and are pleased that the project is now being taken up on a large scale by an experienced company," says enaCom director Sandra Speer.

Settlement in the Gründer- und Technologiezentrum Rheinbach

The Clickmer Systems team consisting of project leader Dr. Joachim Schorr, Dr. Nora Karnowski, Dr. Maren Hamann, Dr. Johanna Kauppila and Stefanie Büsch will continue to research and grow under the umbrella of APIS Assay Technologies. Networking with the University of Bonn and the region will continue, as Clickmer Systems will move into premises at the Gründer- und Technologiezentrum Rheinbach. "Now we can show what we can do," says a delighted Dr. Nora Karnowski.

From research to commercial development, it has been a busy road for the startup. Mayer has no regrets: "I am excited to work with my motivated team to combine basic research with applications in diagnostics and therapeutics." The researcher, who is also a member of the Transdisciplinary Research Areas (TRA) "Life and Health" and "Building Blocks of Matter and Fundamental Interactions" at the University of Bonn, is pleased that such initiatives also create jobs and promising medical prospects for our society.


APIS Assay Technologies Ltd.:


Prof. Dr. Günter Mayer
LIMES Institute of the University of Bonn
Phone +49-228-732935

Dr. Maren Hamann
Clickmer Systems
Phone +49-163-7953675

Sandra Speer
Transfer Center enaCom of the University of Bonn
Phone +49-228-7362006

Dr. Ian Kavanagh
Chief Operating Officer
APIS Assay Technologies

Record changed: 2024-01-06


Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner BIO 2024 International Convention San Diego 650x300px

» top